Market Cap 37.17M
Revenue (ttm) 0.00
Net Income (ttm) -22.46M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.26
Volume 4,900
Avg Vol 38,802
Day's Range N/A - N/A
Shares Out 3.96M
Stochastic %K 30%
Beta 0.17
Analysts Strong Sell
Price Target $65.00

Latest News on INKT

MiNK Therapeutics, Inc. (INKT) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 2:51 PM EDT - 6 months ago

MiNK Therapeutics, Inc. (INKT) Q2 2024 Earnings Call Transcript


MiNK Reports Second Quarter 2024 Results and Business Update

Aug 13, 2024, 7:00 AM EDT - 6 months ago

MiNK Reports Second Quarter 2024 Results and Business Update


MiNK Therapeutics Announces Virtual Annual Shareholders Meeting

Jun 5, 2024, 7:30 AM EDT - 9 months ago

MiNK Therapeutics Announces Virtual Annual Shareholders Meeting


MiNK Therapeutics, Inc. (INKT) Q1 2024 Earnings Call Transcript

May 14, 2024, 11:07 AM EDT - 9 months ago

MiNK Therapeutics, Inc. (INKT) Q1 2024 Earnings Call Transcript


MiNK Reports First Quarter 2024 Results

May 14, 2024, 7:30 AM EDT - 9 months ago

MiNK Reports First Quarter 2024 Results


MiNK Therapeutics, Inc. (INKT) Q4 2023 Earnings Call Transcript

Mar 21, 2024, 2:20 PM EDT - 11 months ago

MiNK Therapeutics, Inc. (INKT) Q4 2023 Earnings Call Transcript


MiNK Reports Fourth Quarter and Year-End 2023 Results

Mar 21, 2024, 7:00 AM EDT - 11 months ago

MiNK Reports Fourth Quarter and Year-End 2023 Results


MiNK Therapeutics Reports Third Quarter 2023 Results

Nov 9, 2023, 7:00 AM EST - 1 year ago

MiNK Therapeutics Reports Third Quarter 2023 Results


MiNK Therapeutics Reports Second Quarter 2023 Results

Aug 10, 2023, 7:30 AM EDT - 1 year ago

MiNK Therapeutics Reports Second Quarter 2023 Results


MiNK's Novel FAP-CAR-iNKT Presented at ASGCT

May 18, 2023, 8:30 AM EDT - 1 year ago

MiNK's Novel FAP-CAR-iNKT Presented at ASGCT


MiNK Therapeutics, Inc. (INKT) Q4 2022 Earnings Call Transcript

Mar 21, 2023, 12:26 PM EDT - 2 years ago

MiNK Therapeutics, Inc. (INKT) Q4 2022 Earnings Call Transcript


MiNK Therapeutics Undervalued Given Potential Of Platform

Dec 5, 2022, 10:43 PM EST - 2 years ago

MiNK Therapeutics Undervalued Given Potential Of Platform